BFRI Stock Analysis: Buy, Sell, or Hold?
BFRI - Biofrontera Inc. Common Stock
$0.90
0.03 (4.03%)
▲
5d:
-3.23%
30d:
-8.96%
90d:
+1.18%
HOLD
MODERATE Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When BFRI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BFRI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BFRI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.78
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.73
47.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BFRI is currently trading at $0.90, which is considered fair relative to its 30-day fair value range of $0.81 to $1.02. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.7) compared to its historical average (6.2). Remarkably, the market is currently pricing in an annual earnings decline of 24.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BFRI is in a strong uptrend. Immediate support is located at $0.84, while resistance sits at $1.05. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: BFRI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.88 (+579.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BFRI is in a strong uptrend. Immediate support is located at $0.84, while resistance sits at $1.05. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: BFRI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.88 (+579.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.81 -
$1.02
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.8%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 579.1% below Wall St target ($5.88)
Trading Range Analysis
30-Day Trading Range
$0.81 -
$1.02
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.84
Resistance Level
$1.05
Current Trend
Strong Uptrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.70
Wall Street Target
$5.88
(+579.1%)
Revenue Growth (YoY)
17.4%
Profit Margin
-25.7%
Valuation Discount vs History
-24.0% cheaper
PE vs Historical
2.7 vs 6.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-24.0%
(market-implied from PE analysis)
1-Year Target
$0.78
(-10%)
2-Year Target
$0.70
(-19%)
3-Year Target
$0.63
(-27%)
3-Yr Target (if PE normalizes)
(PE: 3→6)
$1.45
(+67%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.7 to 6.2
Stabilization Target:
$1.98
(+129.3%)
PE Expansion Potential:
+129.3%
Share & Embed Analysis
Last updated: June 15, 2026 10:02 AM ET
Data refreshes hourly during market hours. Next update: 11:02 AM
Data refreshes hourly during market hours. Next update: 11:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BFRI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$193 | 64 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 60 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 65 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 57 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 59 HOLD |
